Abstract:Highlights • Tetrahedral framework nucleic acid (FNA) nanomaterials-mediated microRNAs (miRNAs) were involved in the hepatocyte differentiation of human adipose-derived mesenchymal stem cells (ADMSCs). • A simple and cost-effective system was established to one-step induce hepatic differentiation of ADMSCs, and further develop liver organoids from induced functional hepatocyte-like cells. • Transcriptome analysis revealed the potential action mechanism of inducing ADMSCs to differentiate into hepatocytes based on FNA-miRNA, which could be an extendable strategy for other small RNA. • Cell therapy based on HLCs and Hep:HUE-Liver spheroids represented a promising strategy for effective acute liver failure therapy. The specific induction of hepatic differentiation presents a significant challenge in developing alternative liver cell sources and viable strategies for clinical therapy of acute liver failure (ALF). The past decade has witnessed the blossom of microRNAs in regenerative medicine. Herein, microRNA 122-functionalized tetrahedral framework nucleic acid (FNA-miR-122) has emerged as an unprecedented and potential platform for directing the hepatic differentiation of adipose-derived mesenchymal stem cells (ADMSCs), which offers a straightforward and cost-effective method for generating functional hepatocyte-like cells (FNA-miR-122-iHep). Additionally, we have successfully established a liver organoid synthesis strategy by optimizing the co-culture of FNA-miR-122-iHep with endothelial cells (HUVECs), resulting in functional Hep:HUE-liver spheroids. Transcriptome analysis not only uncovered the potential molecular mechanisms through which miR-122 influences hepatic differentiation in ADMSCs, but also clarified that Hep:HUE-liver spheroids could further facilitate hepatocyte maturation and improved tissue-specific functions, which may provide new hints to be used to develop a hepatic organoid platform. Notably, compared to transplanted ADMSCs and Hep-liver spheroid, respectively, both FNA-miR-122-iHep-based single cell therapy and Hep:HUE-liver spheroid-based therapy showed high efficacy in treating ALF in vivo. Collectively, this research establishes a robust system using microRNA to induce ADMSCs into functional hepatocyte-like cells and to generate hepatic organoids in vitro, promising a highly efficient therapeutic approach for ALF. Graphical abstract Download: Download high-res image (285KB) Download: Download full-size image

Dual–mode action of scalable, high–quality engineered stem cell–derived SIRPα–extracellular vesicles for treating acute liver failure

A Simple and Efficient Strategy for Cell-Based and Cell-Free Based Therapies in Acute Liver Failure: Hucmscs Bioartificial Liver

Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure

Bone marrow mesenchymal stem cell-derived small extracellular vesicles promote liver regeneration via miR-20a-5p/PTEN

Long-term expanded hepatic progenitor cells ameliorate D-GalN/LPS-induced acute liver failure through repolarizing M1 macrophage to M2-Like phenotype via activation of the IL-10/JAK2/STAT3 signaling pathway

Significantly enhanced recovery of acute liver failure by liver targeted delivery of stem cells via heparin functionalization

The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats

Superior Performance of Co-Cultured Mesenchymal Stem Cells and Hepatocytes in Poly(lactic Acid-Glycolic Acid) Scaffolds for the Treatment of Acute Liver Failure.

Extracellular vesicles derived from human ESC–MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury

Human liver progenitor-like cells-derived extracellular vesicles promote liver regeneration during acute liver failure

Framework nucleic Acid-MicroRNA mediated hepatic differentiation and functional hepatic spheroid development for treating acute liver failure

Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure

Mesenchymal Stem Cells Secreted-Prostaglandin E2 Ameliorates Acute Liver Failure Via Attenuation Cell Death and Regulation of Macrophage Polarization

A Biomimetic Multifunctional Nanoframework for Symptom Relief and Restorative Treatment of Acute Liver Failure

Mesenchymal Stem Cell Therapy in Acute Liver Failure

Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation

The Immunoregulatory and Regenerative Potential of Activated Human Stem Cell Secretome Mitigates Acute-on-Chronic Liver Failure in a Rat Model

Role of Mesenchymal Stem Cells, Their Derived Factors, and Extracellular Vesicles in Liver Failure

Human Endoderm Stem Cells Reverse Acute Liver Failure Through Cystatin SN-Mediated Inhibition of Interferon Signaling

3D printing incorporating gold nanozymes with mesenchymal stem cell-derived hepatic spheroids for acute liver failure treatment

Human embryonic stem cell-derived immunity-and-matrix regulatory cells promote intrahepatic cell renewal to rescue acute liver failure